Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126121901 | 12612190 | 1 | I | 20160726 | 20160801 | 20160801 | EXP | BR-JNJFOC-20160725949 | JANSSEN | ANTONIO JR, CAGNON GV, GODOY MF, SANMIGUEL J, AUGUSTO MS, POZETTI EM. INFLIXIMAB IN PATIENTS WITH PSORIASIS AND OTHER INFLAMMATORY DISEASES: EVALUATION OF ADVERSE EVENTS IN THE TREATMENT OF 168 PATIENTS. AN BRAS DERMATOL 2016;91(3):306-10. | 41.00 | YR | A | F | Y | 0.00000 | 20160801 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126121901 | 12612190 | 1 | SS | INFLIXIMAB, RECOMBINANT | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | U | 0 | LYOPHILIZED POWDER | |||||||||
| 126121901 | 12612190 | 2 | SS | INFLIXIMAB, RECOMBINANT | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | U | 0 | LYOPHILIZED POWDER | |||||||||
| 126121901 | 12612190 | 3 | SS | INFLIXIMAB, RECOMBINANT | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | U | 0 | LYOPHILIZED POWDER | |||||||||
| 126121901 | 12612190 | 4 | PS | INFLIXIMAB, RECOMBINANT | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | U | 103772 | LYOPHILIZED POWDER |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126121901 | 12612190 | 1 | Colitis ulcerative |
| 126121901 | 12612190 | 2 | Crohn's disease |
| 126121901 | 12612190 | 3 | Ankylosing spondylitis |
| 126121901 | 12612190 | 4 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126121901 | 12612190 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126121901 | 12612190 | Lupus-like syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |